PREDICTING THE RISK OF ATRIAL FIBRILLATION AND CORONARY HEART DISEASE DEVELOPMENT WITH MUTATION OF HEMOSTASIS SYSTEM GENES

Aim. This study was conducted to assess the risk of atrial fibrillation and coronary heart disease development with mutation of hemostasis system genes.Materials and methods. Genes polymorphisms of factor GII210A II (FII), G169A factor V (FV), Arg 353G1p factor VII (FVII), C677T MTHFR, 22Met (66a-g)...

Full description

Saved in:
Bibliographic Details
Main Authors: D. I. Panchenko, A. S. Adamchik
Format: Article
Language:Russian
Published: Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2018-10-01
Series:Кубанский научный медицинский вестник
Subjects:
Online Access:https://ksma.elpub.ru/jour/article/view/1357
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250504441331712
author D. I. Panchenko
A. S. Adamchik
author_facet D. I. Panchenko
A. S. Adamchik
author_sort D. I. Panchenko
collection DOAJ
description Aim. This study was conducted to assess the risk of atrial fibrillation and coronary heart disease development with mutation of hemostasis system genes.Materials and methods. Genes polymorphisms of factor GII210A II (FII), G169A factor V (FV), Arg 353G1p factor VII (FVII), C677T MTHFR, 22Met (66a-g) MTRR, 675 5G / 4G PAI type 1 and 455G-A fibrinogen β (FGB) were examined in the patients of the main group and control group. The genotyping was carried out by PCR method using competing TagMan probes complementary to the polymorphic region of DNA.Results. As a result of the research, there was identified a reliable prognostic risk of the development of coronary heart disease (CHD) and atrial fibrillation paroxysms (AFP) in patients with mutations of the VII blood coagulation factor genes, mutations in the MTHFR gene, mutations in the MTRR gene.Conclusion. The obtained results indicate the risk of CHD and AFP development in patients with mutations of the VII gene of the clotting factor, mutation in the MTHFR gene and mutation in the MTRR gene. It may be the basis for early diagnosis, monitoring and treatment of this category of patients.
format Article
id doaj-art-f2d30facb5c14ce2a6f5ea5151952dee
institution Kabale University
issn 1608-6228
2541-9544
language Russian
publishDate 2018-10-01
publisher Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
record_format Article
series Кубанский научный медицинский вестник
spelling doaj-art-f2d30facb5c14ce2a6f5ea5151952dee2025-08-20T03:57:13ZrusMinistry of Healthcare of the Russian Federation. “Kuban State Medical University”Кубанский научный медицинский вестник1608-62282541-95442018-10-0125514715110.25207/1608-6228-2018-25-5-147-1511018PREDICTING THE RISK OF ATRIAL FIBRILLATION AND CORONARY HEART DISEASE DEVELOPMENT WITH MUTATION OF HEMOSTASIS SYSTEM GENESD. I. Panchenko0A. S. Adamchik1Federal State Budget Educational Institution of Higher Education "Kuban State Medical University" of the Ministry of Health of the Russian FederationFederal State Budget Educational Institution of Higher Education "Kuban State Medical University" of the Ministry of Health of the Russian FederationAim. This study was conducted to assess the risk of atrial fibrillation and coronary heart disease development with mutation of hemostasis system genes.Materials and methods. Genes polymorphisms of factor GII210A II (FII), G169A factor V (FV), Arg 353G1p factor VII (FVII), C677T MTHFR, 22Met (66a-g) MTRR, 675 5G / 4G PAI type 1 and 455G-A fibrinogen β (FGB) were examined in the patients of the main group and control group. The genotyping was carried out by PCR method using competing TagMan probes complementary to the polymorphic region of DNA.Results. As a result of the research, there was identified a reliable prognostic risk of the development of coronary heart disease (CHD) and atrial fibrillation paroxysms (AFP) in patients with mutations of the VII blood coagulation factor genes, mutations in the MTHFR gene, mutations in the MTRR gene.Conclusion. The obtained results indicate the risk of CHD and AFP development in patients with mutations of the VII gene of the clotting factor, mutation in the MTHFR gene and mutation in the MTRR gene. It may be the basis for early diagnosis, monitoring and treatment of this category of patients.https://ksma.elpub.ru/jour/article/view/1357atrial fibrillationgene polymorphisms of hemostasis
spellingShingle D. I. Panchenko
A. S. Adamchik
PREDICTING THE RISK OF ATRIAL FIBRILLATION AND CORONARY HEART DISEASE DEVELOPMENT WITH MUTATION OF HEMOSTASIS SYSTEM GENES
Кубанский научный медицинский вестник
atrial fibrillation
gene polymorphisms of hemostasis
title PREDICTING THE RISK OF ATRIAL FIBRILLATION AND CORONARY HEART DISEASE DEVELOPMENT WITH MUTATION OF HEMOSTASIS SYSTEM GENES
title_full PREDICTING THE RISK OF ATRIAL FIBRILLATION AND CORONARY HEART DISEASE DEVELOPMENT WITH MUTATION OF HEMOSTASIS SYSTEM GENES
title_fullStr PREDICTING THE RISK OF ATRIAL FIBRILLATION AND CORONARY HEART DISEASE DEVELOPMENT WITH MUTATION OF HEMOSTASIS SYSTEM GENES
title_full_unstemmed PREDICTING THE RISK OF ATRIAL FIBRILLATION AND CORONARY HEART DISEASE DEVELOPMENT WITH MUTATION OF HEMOSTASIS SYSTEM GENES
title_short PREDICTING THE RISK OF ATRIAL FIBRILLATION AND CORONARY HEART DISEASE DEVELOPMENT WITH MUTATION OF HEMOSTASIS SYSTEM GENES
title_sort predicting the risk of atrial fibrillation and coronary heart disease development with mutation of hemostasis system genes
topic atrial fibrillation
gene polymorphisms of hemostasis
url https://ksma.elpub.ru/jour/article/view/1357
work_keys_str_mv AT dipanchenko predictingtheriskofatrialfibrillationandcoronaryheartdiseasedevelopmentwithmutationofhemostasissystemgenes
AT asadamchik predictingtheriskofatrialfibrillationandcoronaryheartdiseasedevelopmentwithmutationofhemostasissystemgenes